Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
101.9 EUR | -0.78% | +0.44% | -10.85% |
May. 31 | Wacker Chemie AG completed the acquisition of Assets of Bio Med Sciences Inc. | CI |
May. 07 | WACKER CHEMIE AG : Gets a Neutral rating from DZ Bank | ZD |
Summary
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.87 for the current period. Therefore, the company is undervalued.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-10.85% | 5.49B | A- | ||
-4.05% | 19.39B | - | ||
+5.08% | 4.19B | B | ||
+17.49% | 1.59B | B | ||
+2.84% | 1.31B | B- | ||
+19.82% | 959M | - | ||
-11.55% | 688M | - | - | |
-36.36% | 566M | - | ||
-13.97% | 290M | - | - | |
-12.92% | 252M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- WCH Stock
- Ratings Wacker Chemie AG